A new indication of sildenafil in medicine: hypoxic cell sensitizer for penile cancer.
J Cancer Res Ther
;
2006 Jul-Sep; 2(3): 132-5
Artículo
en Inglés
| IMSEAR
| ID: sea-111403
ABSTRACT
PURPOSE:
To evaluate the feasibility and results of sildenafil used as radiosensitizer by causing penile vasodilatation and reducing tumor hypoxia in radical radiotherapy for penile cancer. MATERIALS ANDMETHODS:
Three men with histopathologic diagnosis of squamous carcinoma of penis were treated with radical external radiotherapy with concomitant sildenafil. Acute and late adverse events were noted according to RTOG toxicity criteria. Response to radiotherapy, as well as disease-free and overall survivals, was evaluated.RESULTS:
All three patients achieved tumescence, completed the treatment and achieved complete response. One patient had recurrence at 10 months and died of the disease after 23 months from starting the treatment. Other two patients are disease-free and alive at 48 and 53 months respectively. No excess acute or late adverse event was observed.CONCLUSION:
Sildenafil may act as radiosensitizer by causing penile vasodilatation and reducing hypoxia. Larger controlled studies are required to validate the hypothesis.
Texto completo:
Disponible
Índice:
IMSEAR (Asia Sudoriental)
Asunto principal:
Neoplasias del Pene
/
Inhibidores de Fosfodiesterasa
/
Piperazinas
/
Purinas
/
Sulfonas
/
Anciano de 80 o más Años
/
Humanos
/
Masculino
/
Carcinoma
/
Hipoxia de la Célula
Límite:
Aged80
Idioma:
Inglés
Revista:
J Cancer Res Ther
Asunto de la revista:
Neoplasms
/
Therapeutics
Año:
2006
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS